** U.S.-listed shares of Germany-based diagnostic and pharma
co CNTG.O fall ~23% to hit a record low at $7
** Stock set for biggest pct fall since its 2019 debut
** CNTG flags uncertainty about its ability to continue as a
going concern after posting a wider Q3 loss urn:newsml:reuters.com:*:nGNX21Nqdk
** CNTG's Q3 revenue falls 17% to 30.2 mln euros
** Co reports total loss of 21.6 mln euros ($24.17 mln) , or
0.96 euro per share, vs 5.7 mln euros, or 0.27 euro per shr, a
year earlier
** CNTG down ~34% YTD
($1 = 0.8935 euros)
(Reporting by Deborah Sophia in Bengaluru)
((DeborahMary.Sophia@thomsonreuters.com;))